These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28351466)

  • 21. The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.
    Grimmsmann T; Himmel W
    Eur J Clin Pharmacol; 2021 Jan; 77(1):107-115. PubMed ID: 32803292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
    Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
    Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
    Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Trends in the Prescribing of ADHD Medications in Canadian Primary Care.
    Morkem R; Patten S; Queenan J; Barber D
    J Atten Disord; 2020 Jan; 24(2):301-308. PubMed ID: 28748725
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trend in medicines use for attention deficit hyperactivity disorder in children and adolescents (2010-2019).].
    Prieto Antolín B; Gutiérrez-Abejón E; Alberola López S; Andrés de Llano JM
    Rev Esp Salud Publica; 2022 Mar; 96():. PubMed ID: 35318300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
    Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
    Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regional differences of ADHD diagnosis rates in health insurance data from 2005 to 2015 : Methodological considerations and results].
    Grobe TG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Dec; 60(12):1336-1345. PubMed ID: 29052741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe].
    Häge A; Banaschewski T; Dittmann RW
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):676-85. PubMed ID: 26714249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
    Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
    J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.
    Stuhec M; Locatelli I
    Int J Clin Pharm; 2018 Apr; 40(2):341-344. PubMed ID: 29468526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of attention deficit hyperactivity disorder in adults].
    Retz W; Retz-Junginger P; Davydenko S; Rösler M
    Nervenarzt; 2020 Jul; 91(7):583-590. PubMed ID: 32232533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
    Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S
    Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attention deficit hyperactivity disorder in childhood and adolescence : Current state of research].
    Häge A; Hohmann S; Millenet S; Banaschewski T
    Nervenarzt; 2020 Jul; 91(7):599-603. PubMed ID: 32270222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study.
    Karam RG; Breda V; Picon FA; Rovaris DL; Victor MM; Salgado CA; Vitola ES; Silva KL; Guimarães-da-Silva PO; Mota NR; Caye A; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Psychol Med; 2015 Jul; 45(10):2045-56. PubMed ID: 25612927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany.
    Braun S; Russo L; Zeidler J; Linder R; Hodgkins P
    Clin Ther; 2013 May; 35(5):673-85. PubMed ID: 23587606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
    Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
    J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
    King SA; Casavant MJ; Spiller HA; Hodges NL; Chounthirath T; Smith GA
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29784754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescriptions for ADHD medication, 2004-08.
    Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
    Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.